<img alt="" src="https://secure.wake4tidy.com/244317.png" style="display:none;">

Vironova have received a certificate of GMP compliance of a manufacturer from the Swedish Medical Products Agency

Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency


Latest webinar now available on-demand

The Vironova team of Josefina Nilsson, Head EM services and Martin Ryner, Manager Strategic Development presented a webinar on the 11th April with over 200 people participating.


Two Vironova patent applications have successfully passed the international phase

Two Vironova patent applications have successfully passed the international phase We’re very pleased to announce that our patent "A method for quantification of purity of sub-visible particle samples" has now passed the PCT (international patent...


MiniTEM contributes to the success of our customers – good testimonials at the Cell & Gene therapy conference in Amsterdam.

The event at Cell & Gene Therapy in Amsterdam this week was a successful showcase for MiniTEM. Apart from our own activities at our booth and a presentation in the main program we also received an excellent testimonial from Hanna Lesch, Research and...


Vironova’s CEO, Mohammed Homman, has been elected onto IVA’s Business Executives Council (Näringslivsrådet)

The Royal Swedish Academy of Engineering Sciences (Kungl. Ingenjörsvetenskapsakademien, IVA), Business Executives Council met on the 29th November for their annual meeting at which we are proud to announce that Vironova’s CEO, Mohammed Homman was...


Vironova awarded funding to advance expertise in AI

We are proud to announce that Vironova has been awarded funding for a two-year research project entitled “Interactive visualization tools for verification and improvement of deep neural network predictions.” The project will stretch over two years...


A new industry report illustrates how Vironova’s market is expanding

A report entitled “State of the global biomanufacturing and bioprocessing industry 2017” was published in September 2017 by William Reed’s BioPharma-Reporter. The report is based on a state-of-the-industry survey, answered by more than 350 people,...


New publication together with FinVector OY on the application of MiniTEM in gene therapy

Vironova has published a new article on BioProcess International today together with our friends at FinVector Vision Therapies Oy, Finland. It's a detailed explanation of how MiniTEM can be used for gene therapy applications and well worth a read....


Did you miss the Vironova workshop September 26 at Biotech Week Boston?

Slides with audio recording of the presentation by Mathieu Colomb-Delsuc, Senior Scientist Vironova. Now available on demand. Download the webinar by clicking the link below.


Vironova ranked as one of Sweden’s 50 fastest growing technology companies.

Deloitte’s Sweden Technology Fast 50 is a ranking of Sweden's 50 fastest growing technology companies, based on growth in net sales over the past four years. The rankings include both public and private companies, covering all types of technology,...